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Abstract
Chlamydia is an obligate intracellular pathogen that causes a wide range of diseases in humans. Attachment and entry are
key processes in infectivity and subsequent pathogenesis of Chlamydia, yet the mechanisms governing these interactions
are unknown. It was recently shown that a cell line, CHO6, that is resistant to attachment, and thus infectivity, of multiple
Chlamydia species has a defect in protein disulfide isomerase (PDI) N–terminal signal sequence processing. Ectopic
expression of PDI in CHO6 cells led to restoration of Chlamydia attachment and infectivity; however, the mechanism leading
to this recovery was not ascertained. To advance our understanding of the role of PDI in Chlamydia infection, we used RNA
interference to establish that cellular PDI is essential for bacterial attachment to cells, making PDI the only host protein
identified as necessary for attachment of multiple species of Chlamydia. Genetic complementation and PDI-specific
inhibitors were used to determine that cell surface PDI enzymatic activity is required for bacterial entry into cells, but
enzymatic function was not required for bacterial attachment. We further determined that it is a PDI-mediated reduction at
the cell surface that triggers bacterial uptake. While PDI is necessary for Chlamydia attachment to cells, the bacteria do not
appear to utilize plasma membrane–associated PDI as a receptor, suggesting that Chlamydia binds a cell surface protein
that requires structural association with PDI. Our findings demonstrate that PDI has two essential and independent roles in
the process of chlamydial infectivity: it is structurally required for chlamydial attachment, and the thiol-mediated oxido-
reductive function of PDI is necessary for entry.
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Introduction
Fundamental to understanding of intracellular bacterial path-
ogenesis is knowledge of the mechanism of bacterial attachment
and subsequent entry into cells. There are two main processes by
which bacteria stimulate their entry into nonphagocytic cells: by
bacterial contact mediated activation of a cell surface receptor (the
‘‘zipper’’ mechanism) or by injecting bacterial proteins into the cell
cytosol (the ‘‘trigger’’ mechanism) [1,2]. Once the bacterial and
host factors involved in the invasion process are identified this
knowledge can be employed to devise antimicrobial strategies that
target cellular infection. Blockade of this first step of bacterial
infection is ideal for intracellular bacteria as these pathogens are
able to avoid a number of host defenses by residing within cells.
Chlamydia is an obligate intracellular bacteria that can infect a
number of different eukaryotic cells. Human chlamydial infection
causes a wide range of pathologies. Chlamydia is the most common
bacterial sexually transmitted disease [3], the leading cause of
infectious blindness [4], and a community acquired respiratory
pathogen [5]. Chlamydia infects cells as a metabolically inactive
elementary body (EB) and then once within cells differentiates into
the metabolically active but noninfectious form known as the
reticulate body (RB). The EB are small (0.3-mm) and have a rigid
outer membrane consisting of a mesh of disulfide cross-linked
cysteine-rich proteins [6]. This membrane structure causes the EB
to be osmotically stable and thus resistant to the stresses of the
extracellular environment [7]. The RB, which is much larger (1-
mm), is not osmotically stable owing to a decrease in disulfide cross-
linked envelope proteins. Following replication the RB condense
back into EB in a process that involves the expression of EB-
specific disulfide-rich proteins and oxido-reductive processing.
These EB can then infect neighboring cells or new hosts.
Attachment and entry into cells are key steps in chlamydial
development and pathogenesis, yet the mechanism governing
these interactions is still unknown. A number of bacterial ligands,
including the major outer membrane protein [8], glycosamino-
glycans [9,10], heat shock protein 70 [11], and OmcB [12,13]
have been implicated in the process. It is likely that a host
proteinacious factor(s) is involved in Chlamydia attachment as
infectivity is lost following mild trypsin treatment of cells [14].
Several host proteins including: epithelial membrane protein 2
[15], mannose 6-phosphate receptor [16], the estrogen receptor
complex [17], platelet-derived growth factor receptor [18], and
protein disulfide isomerase (PDI) [17,19] influence Chlamydia
attachment. However, only one mammalian protein, PDI, has
been demonstrated to be involved in attachment of multiple
species and serovars of Chlamydia [19].
The role for PDI in Chlamydia infection was originally elucidated
by proteomic analysis of CHO6 cells. CHO6 cells were generated
by chemical mutagenesis of Chlamydia-susceptible CHOK1 cells
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pneumoniae, and C. psittaci [20]. CHO6 have a defect in PDI
processing and express two forms of the protein. CHO6 express
full length PDI, which is found in the parental cell line CHOK1,
as well as a truncated form lacking the N-terminal signal sequence
that is unique to CHO6 cells [19]. This truncated form of PDI
present in CHO6 is not the result of a mutation in PDI itself but is
instead likely due to an unidentified processing defect in CHO6
cells [19]. It was determined that ectopic expression of full length
PDI in CHO6 rescues chlamydial attachment and consequently
infectivity [19].
PDI is a multi-functional protein: it catalyzes the reduction,
oxidation, and isomerization of disulfide bonds, it can act as a
chaperone or anti-chaperone [21], and PDI is a subunit of
collagen prolyl 4-hydroxylase and microsomal triglyceride trans-
ferase [22]. PDI consists of five domains. It contains two
thioredoxin-like catalytic domains (a and a9) separated by two
non-catalytic domains (b and b9) and has a small C-terminal
domain (c). The two catalytic domains contain characteristic
CGHC active-site motifs, the cysteines in these sites are essential
for PDI enzymatic activity [23]. An ER retention signal (KDEL) is
located at the C-terminal of PDI, PDI also has an N-terminal
signal sequence. PDI is highly enriched in the endoplasmic
reticulum but is also found in the cytosol, nucleus, and on the cell
surface [24]. PDI reductive function at the cell surface has been
shown to be essential for entry of a number of different viruses
[25–28], as well as being necessary for activating diphtheria toxin
[29].
It is known that PDI is involved in chlamydial infection [19],
but the precise role of PDI is not clear as PDI has a number of
diverse functions in cells. In this study we evaluated the role of PDI
enzymatic activity in Chlamydia infectivity. We have determined
that although cellular PDI is required for both Chlamydia
attachment and entry the requirement is mechanistically different
in the two processes. PDI cell surface enzymatic activity was
necessary for entry of bacteria into cells. In contrast Chlamydia
attachment to host cells required PDI but was independent of cell
surface PDI enzymatic activity.
Results
Cellular PDI is necessary for Chlamydia attachment
CHO6 cells, which have a mutation that affects PDI processing
[19], are resistant to attachment of multiple species of Chlamydia
[20]. It has previously been shown that chlamydial infectivity of
CHO6 can be rescued by expression of recombinant PDI [19],
suggesting that PDI is involved in bacterial attachment. The
mutation in CHO6 leading to differential processing of PDI and
consequent lack of Chlamydia attachment is unknown. PDI is
essential for cell viability, thus gene disruption approaches cannot
be used to test if PDI is necessary for Chlamydia attachment or if
additional mutations play a role in the phenotype of the CHO6
cell line. In contrast, siRNA has been used to transiently
knockdown expression of PDI in mammalian cells [30]. siRNA-
mediated downregulation of PDI was used to test whether PDI
alone is required for Chlamydia infectivity. HeLa cells were
transfected with PDI-targeting siRNA and PDI knockdown was
assessed by immunoblot. Approximately 80–90% reduction in
PDI expression was achieved (Figure 1A). When PDI was depleted
from HeLa cells bacteria were no longer able to attach to and thus
infect cells (Figure 1B). The degree of chlamydial attachment to
siRNA treated cells was quantified by counting the number of
bacteria attached to cells. Following PDI depletion there were only
0.6961.04 C. psittaci and 1.2761.39 C. trachomatis per cell, a 97.8%
and 97.7% reduction in attachment respectively (Figure 1C).
These results demonstrate that cellular PDI is essential for
attachment of Chlamydia to the surface of host cells, making PDI
the only host protein identified that is required for Chlamydia
attachment.
Enzymatically nonfunctional PDI can restore Chlamydia
attachment but not entry into CHO6 cells
To further characterize the nature of the PDI requirement in
Chlamydia infectivity, we tested the hypothesis that the oxido-
reductive or cysteine isomerase roles of PDI were required for
restoration of Chlamydia attachment and entry to CHO6 cells. The
catalytic domain of PDI is well characterized and specific amino
acids involved in PDI isomerase activity have been identified [31].
The role of PDI enzymatic activity in chlamydial infectivity was
analyzed by generating recombinant PDI with disabled catalytic
domains. This was accomplished by converting the four key
cysteine residues within the catalytic domains to serine (PDI-4CS).
Although PDI-4CS is no longer able to reduce, oxidize, or
rearrange disulfide bonds it can still fulfill PDI chaperone, anti-
chaperone, and structural roles [31].
Prior to examination of Chlamydia infectivity restoration in cells
expressing PDI-4CS, cell surface PDI enzymatic activity was
evaluated. Plasma membrane PDI activity can be tested by cellular
sensitivity to diphtheria toxin (DT) as cell surface PDI enzymatic
activity is required for DT-mediated killing of cells. PDI reduces
interchain disulfide bonds in DT triggering chain separation that
then allows for translocation of DT chain A across the membrane
and subsequent toxin-induced cell death [29]. CHO6 cells have
aberrant cell surface PDI activity and are resistant to DT. If native
PDI is expressed in CHO6 cells toxin sensitivity is restored [19].
DT sensitivity of CHO6 expressing native PDI (CHO6+PDI) or
CHO6 expressing enzymatically disabled PDI (CHO6+PDI-4CS)
were tested. As previously reported, CHO6+PDI became sensitive
to toxin (Figure 2), whereas CHO6 cells expressing PDI lacking
enzymatic function (CHO6+PDI-4CS) were largely resistant to
DT (Figure 2). These results demonstrated that cell surface PDI
enzymatic activity is rescued in CHO6 following expression of
native PDI but not in cells expressing PDI lacking enzymatic
Author Summary
Chlamydia is a large burden on global health. It is the most
common cause of infectious blindness, and the CDC
(Centers for Disease Control and Prevention) estimates
that in the United States alone there are more than 2
million people with sexually transmitted Chlamydia
infections. Chlamydia is an obligate intracellular bacteria;
thus, attachment and subsequent invasion of cells are key
steps in Chlamydia pathogenesis. While strides have been
made in understanding the molecular mechanism of
Chlamydia infection, fundamental aspects of this process
still remain elusive. We have identified a host protein,
protein disulfide isomerase (PDI), that is essential for
Chlamydia attachment as well as for entry into cells. Cell-
surface PDI-mediated disulfide reduction is required for
Chlamydia entry into cells, whereas bacterial attachment is
independent of PDI enzymatic activity. Although PDI is
necessary for Chlamydia attachment, the bacteria appar-
ently does not bind directly to cell-associated PDI,
suggesting that Chlamydia attaches to a host protein(s)
associated with PDI. This study advances our understand-
ing of Chlamydia pathogenesis by the characterization of a
host factor essential for independent stages of bacterial
attachment and entry.
PDI and Chlamydia Infectivity
PLoS Pathogens | www.plospathogens.org 2 April 2009 | Volume 5 | Issue 4 | e1000357function. These data establish a model that can be used to
specifically address the role of plasma membrane PDI enzymatic
activity in Chlamydia infectivity.
CHO6 cells were transfected with vectors expressing native PDI
or PDI-4CS and both attachment and entry were separately
evaluated. Despite lacking PDI enzymatic activity at the cell
surface, CHO6 cells transfected with PDI-4CS showed equivalent
Chlamydia attachment as cells transfected with native PDI
(Figure 3A). The level of attachment recovery was quantified by
counting the number of bacteria associated with cells (Figure 3B).
These data show that while PDI is necessary for chlamydial
attachment, the function of PDI in attachment is independent of
the protein’s enzymatic activity.
Because PDI that is enzymatically nonfunctional could restore
bacterial attachment to the cell, the ability of Chlamydia to establish
a productive infection in cells expressing the parental or enzymatic
mutant PDI protein was evaluated (Figure 3C). The development
of Chlamydia laden vacuoles was only observed in the parental
CHOK1 and CHO6 cells expressing PDI (Figure 3C). Infection
rescue was quantified by determining the number of inclusion per
field of view (Figure 3D), no inclusion were seen in CHO6 cells or
CHO6 cells expressing PDI-4CS. It was noted that despite the lack
of productive infection of CHO6+PDI-4CS, many of the bacteria
remained persistently attached to the cells throughout the 24 h
course of the experiment (Figure 3C).
Enzymatically nonfunctional PDI was capable of rescuing
attachment but not infectivity. This outcome could be the result
of an enzymatic role for PDI in either cellular entry or in other
chlamydial developmental processes soon after entry that may
prevent growth. Chlamydial entry was evaluated by allowing
attached Chlamydia to enter cells by shifting them to 37u C for 2 h.
Entry was analyzed by comparing the number of surface bound
bacteria by immunofluorescence staining of unpermeabilized cells
between CHO6+PDI versus CHO6+PDI-4CS. After 2 h at 37uC,
entry was restored in CHO6+PDI with 95.7% of bacteria
internalized following the 2 h incubation (Figure 3E and 3F). In
contrast, there was no significant internalization of Chlamydia that
had attached to CHO6+PDI-4CS (Figure 3E and 3F). Although
PDI, independent of its enzymatic function was sufficient to
Figure 1. siRNA downregulation of PDI inhibits attachment of Chlamydia. (A) Immunoblot of cells transfected with PDI-targeted siRNA or
non-targeting siRNA using antibody to PDI. GAPDH expression was evaluated to ensure equivalent loading. (B) Following siRNA treatment, C. psittaci
and C. trachomatis attachment were examined. PDI staining is shown in red, and bacteria are stained green. Because of the significant PDI
downregulation, cells in PDI siRNA panels are marked by arrows. siRNA downregulation of PDI led to a dramatic decrease in bacterial attachment, but
attachment was not affected by treatment with non-targeting siRNA. (C) The number of bacteria attached to cells following treatment with non-
targeting siRNA (gray) or PDI siRNA (black) was determined by quantification of the number of cell-associated bacteria by counting eight separate
fields of view containing at least ten cells. Error bars indicate standard error of the mean (SEM).
doi:10.1371/journal.ppat.1000357.g001
Figure 2. Cell surface PDI function is restored in CHO6+PDI but
not in CHO6+PDI-4CS. Cell surface PDI enzymatic activity was
assessed by diphtheria toxin (DT) sensitivity assays. Toxin killing of cells
requires plasma membrane PDI function, percent survival was
determined by comparing the level of cell viability in DT treated and
untreated cells. Cells were incubated with 100 ng ml
21 DT, washed,
and then incubated at 37uC. 72 h after toxin treatment, cell viability was
determined by using the Promega CellTiter 96 Aqueous One Cell
Proliferation Assay. CHOK1 cells were sensitive to DT, but CHO6 cells
were not. When PDI was expressed in CHO6 (CHO6+PDI), the cells
became sensitive to DT, indicating that cell surface PDI activity was
restored in CHO6+PDI. Surface PDI activity is not restored in CHO6+PDI-
4CS, as CHO6+PDI-4CS cells were relatively resistant to DT. Error bars
indicate standard error of the mean (SEM).
doi:10.1371/journal.ppat.1000357.g002
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expressing wildtype PDI (CHO6+PDI) or an enzymatic mutant of PDI lacking active site cysteine residues (CHO6+PDI-4CS). 48 h after transfection, cells
were infected with Chlamydia for subsequent attachment and entry analysis. Cells were fixed and evaluated by immunofluorescence, bacteria are
green and counter staining shown with Evans blue. (A) Bacterial attachment was analyzed 1 h post-infection. Bacterial attachment was recovered in
CHO6+PDI as well as in CHO6+PDI-4CS, indicating that PDI enzymatic activity is not necessary for bacterial attachment. (B) The number of bacteria
attached to cells was determined by quantification, the number of bacteria associated with each cell in eight separate fields of view containing at
least ten cells. Error bars indicate standard of deviation (STDEV). (C) 24 h after infection Chlamydia infectivity was evaluated. Infectivity was restored in
CHO6+PDI. No productive infection was observed in CHO6 cells or in CHO6+PDI-4CS. In CHO6+PDI-4CS, the bacteria remained persistently attached
to the cell, indicative of the requirement for PDI enzymatic activity for bacterial entry. (D) Infection was quantified by counting the number of
inclusions per field of view in eight separate fields of view containing at least ten cells. Error bars indicate the STDEV. (E) Cells were incubated at 37uC
for 2 h to allow for bacterial entry. Entry was analyzed by comparing the total number of cell-associated bacteria for staining of permeabilized cells
(Total) and the number of extracellular bacteria determined by staining unpermeabilized cells (Extracellular). Bacterial entry was recovered in CHO6
cells expressing PDI (CHO6+PDI) but not in CHO6 cells expressing enzymatically nonfunctional PDI (CHO6+PDI-4CS). (F) Percent internalization
represents 1 minus the number of extracellular bacteria divided by the total number of bacteria multiplied by 100. The number of extracellular and
total bacteria was determined by quantifying the number of bacteria associated with each cell per field of view in eight separate fields of view
containing at least ten cells. Error bars indicate the STDEV.
doi:10.1371/journal.ppat.1000357.g003
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required for uptake of bacteria into host cells.
From these results it can be concluded that PDI serves two
distinct yet essential functions for Chlamydia attachment and entry.
The role of PDI in attachment is not enzymatic but perhaps
limited to a structural or chaperone function, whereas subsequent
bacterial entry requires PDI enzymatic activity.
Cell surface PDI enzymatic activity is necessary for
Chlamydia entry into cells
Evaluation of Chlamydia infectivity in CHO6 cells expressing
enzymatically nonfunctional PDI indicate that cell surface PDI
activity is required for entry of bacteria but not for attachment.
However, from those experiments it is equivocal if the PDI
enzymatic activity necessary for bacterial entry is occurring at the
cell surface or intracellularly. To specifically test if the required
PDI enzymatic activity was occurring at the cell surface, Chlamydia
attachment and entry were evaluated in CHOK1 cells in the
presence of bacitracin. Bacitracin is a membrane impermeable
PDI-specific inhibitor that has been used to test the role of plasma-
membrane-specific function of PDI in mammalian cells [32–34].
Bacitracin is considered to be a PDI inhibitor because it does not
inhibit thioredoxin mediated reduction [32–34]. The precise
mechanism of bacitracin inhibition of PDI function is not known.
Bacitracin has previously been used with Chlamydia. Davis et al.
[17] found that addition of the inhibitor during infection led to a
16 to 36% decrease in bacterial infectivity. Given the dual role of
PDI in Chlamydia infection illuminated by genetic approaches, we
revisited these early findings by examining the effect of bacitracin-
mediated inhibition of cell surface PDI on not only Chlamydia
infection but also attachment.
CHOK1 cells were inoculated in the presence of bacitracin and
attachment was then evaluated. In the presence of bacitracin
Chlamydia attached to cells at similar levels as untreated cells
(Figure 4A). This demonstrates that extracellular PDI enzymatic
function is not required for chlamydial attachment and supports
the results of our experiments with CHO6 expressing enzymat-
ically nonfunctional PDI (Figure 3A and 3B). The role of plasma
membrane PDI function in Chlamydia entry was examined by
inoculating cells and cultivating them in media containing
bacitracin for 2 h. When bacitracin was present during initial
infection and for the 2 h following attachment Chlamydia were
unable to enter cells and EB remained persistently attached to cells
(Figure 4B). This confirmed that there is a requirement for plasma
membrane PDI activity for chlamydial entry and supports our
previous analyses. The effect of bacitracin on bacterial attachment
and infection was quantified using a quantitative real-time PCR
assay as described previously [35]. When bacitracin was present
the level of attachment was 92.9% that of untreated cells,
indicating that cell surface PDI enzymatic activity is not necessary
for Chlamydia attachment (Figure 4C). In contrast when the level of
infection was quantified 24 h after bacterial attachment, infection
Figure 4. Confirmation that cell surface PDI enzymatic activity is necessary for bacterial entry using bacitracin. (A) Chlamydia
attachment to CHOK1 was evaluated by immunofluorescence staining of bacteria (green) 1 h after infection and counter staining with Evans blue.
Cells were infected and then maintained in media containing 0 mM or 3 mM bacitracin. Similar levels of bacterial attachment were observed with
and without bacitracin. (B) Entry was examined after a 2 h incubation at 37uC. Entry was analyzed by comparing the total number of cell-associated
bacteria (permeabilized) and the number of extracellular bacteria (unpermeabilized). 3 mM bacitracin inhibited bacterial entry. (C) The effect of
bacitracin on Chlamydia attachment and infection was quantified and is shown as the % attachment and infection of cells not treated with bacitracin.
Attachment was analyzed 1 h post-infection and infection was evaluated 24 h post-infection. (D) The effect of bacitracin on Chlamydia development
was examined by evaluating cells 24 h post-infection that had not been treated with bacitracin (a9), been treated with 3 mM bacitracin for 20 min
prior to infection (b9), been treated with bacitracin for the first 8 h of infection (c9), or been treated with bacitracin only for the last 16 h of the 24 h
infection (d9). In all cases the development of bacteria-containing vacuoles was seen, indicative of a normal infection.
doi:10.1371/journal.ppat.1000357.g004
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untreated cells (Figure 4C).
Along with being a PDI-specific inhibitor, bacitracin is also a
bactericidal antibiotic that targets gram-positive bacteria. The
mechanism of bacitracin-mediated bacterial death is that it inhibits
bacterial cell wall synthesis by inhibiting dephosphorylation of
lipid pyrophosphate. Chlamydia is a gram negative-like bacteria, but
it remained important to ensure that the block of bacterial entry by
bacitracin was not simply due to damage to chlamydial organisms
by the inhibitor treatment. We determined that treating cells with
the inhibitor only prior to infection and followed by washing had
no effect on Chlamydia attachment or entry (Figure 4D). Normal
bacterial development was also seen if the inhibitor was removed
or added after the first 8 h of the infection (Figure 4D). The
reversibility of the inhibition demonstrates that the observed effects
were not due to damage to Chlamydia or the cell by the inhibitor
treatment. To ensure that the requirement for PDI enzymatic
activity was not unique to CHOK1 cells attachment and infectivity
analysis with bacitracin was also conducted in HeLa cells. As in
CHOK1 cells Chlamydia attached to HeLa cells in the presence of
bacitracin but were unable to enter (Figure S1).
Using genetics we determined that PDI lacking enzymatic
function was able to complement attachment but not bacterial
entry and subsequent development. DT analysis demonstrated
that following complementation with enzymatically nonfunctional
PDI there was a defect in cell surface PDI activity. The ability of
bacitracin to inhibit bacterial entry, in addition to our results
following PDI expression in CHO6, define an essential role at the
cell surface for PDI enzymatic function in Chlamydia entry.
Cell surface PDI-mediated reduction triggers Chlamydia
entry into cells
Having established that cell surface PDI enzymatic activity was
required for Chlamydia entry into cells we next sought to determine
the molecular mechanism of that activity. PDI is able to reduce,
oxidize, and rearrange disulfide bonds and all three of these
activities are arrested in the presence of bacitracin. Because of the
role of PDI-mediated reduction in viral entry [25–28], we
evaluated if it was a reductive function that was necessary for
Chlamydia entry into cells. CHOK1 cells were infected with
Chlamydia in the presence of bacitracin, arresting infectivity of the
bacteria at the cell surface. The membrane impermeant disulfide
reducing agent TCEP (Tris(2-carboxyethyl)phosphine hydrochlo-
ride) was then added and the cells were incubated at 37u C for 2 h.
The addition of TCEP was able to overcome bacitracin inhibition
of Chlamydia entry, confirming that the stimulus necessary for
bacterial entry into cells is a PDI-mediated reduction occurring at
the cell surface (Figure 5A). Following entry and TCEP removal
Chlamydia were able to establish a productive infection in cells
demonstrating that the bacteria were not damaged by the 2 h
incubation with TCEP (Figure 5B).
The mechanism of bacitracin mediated inhibition of PDI
enzymatic activity is not known, making it possible that TCEP was
simply inhibiting the interaction between PDI and bacitracin and
in that manner restoring bacterial entry. To control for this
possibility the effect of TCEP on entry of Chlamydia into CHO6
cells expressing enzymatically nonfunctional PDI (CHO6+PDI-
4CS) was analyzed. Chlamydia are able to attach to CHO6 cells
expressing PDI-4CS but the bacteria are unable to enter (Figure 3).
When TCEP was added the bacteria were then able to enter the
CHO6 cells expressing non-enzymatically functional PDI
(Figure 5C). From these experiments we can conclude that it is
cell surface PDI mediated reduction that is required for Chlamydia
uptake into cells.
Chlamydia does not directly attach to cell surface PDI
The functional role of PDI in the bacterial attachment stage was
next examined. The most direct hypothesis is that Chlamydia bind
PDI as a receptor. PDI is not an integral membrane protein. PDI
is secreted from cells and then maintained at the surface through
electrostatic interactions with other cell surface proteins [24]. To
test for Chlamydia binding directly to cell surface PDI we generated
a PDI protein that was tethered to the plasma membrane by a C-
terminal gpi anchor. A similar strategy has been used to study the
role of PDI in HIV entry [28]. This plasma membrane anchored
PDI (PDI-gpi) was expressed in CHO6 cells and resulted in high-
level cell surface PDI expression that was readily detectable by
PDI-specific antibody (Figure 6A).
Prior to analysis of bacterial attachment to CHO6 expressing
PDI-gpi, it was first determined if the gpi-anchored PDI was able
to interact with other cell surface proteins in the same manner as
unanchored PDI. This was tested by evaluating DT sensitivity of
cell expressing PDI-gpi. PDI interaction with DT bound to its cell
surface receptor (heparin-binding epidermal growth factor) is
necessary for DT mediated cell death [36]. Whereas toxin
sensitivity is recovered by expression of unanchored PDI
(Figure 2), the gpi-anchored PDI was unable to normally interact
with other cell surface proteins and could not restore DT
sensitivity to CHO6 cells (Figure 6B). The high-level of PDI-gpi
expression did not interfere with normal cell surface interaction, as
it did not reduce CHOK1 toxin sensitivity (Figure 6B). From these
results we could conclude that CHO6 expressing PDI-gpi
functioned as a model for testing if Chlamydia was able to directly
attach to PDI independent of PDI interactions with other cell
surface proteins. Chlamydia attachment to CHO6 cells expressing
PDI-gpi was evaluated, no recovery of bacterial attachment was
observed (Figure 6C). These results suggest there is a lack of
Chlamydia binding directly to PDI.
The experiments with the gpi-anchored PDI are indicative of a
lack of direct attachment on Chlamydia to PDI, but the possibility
that the gpi-anchor was causing a structural change in PDI that led
to the lack of bacterial attachment could not be ruled out. To
address this possibility the effect of polyclonal PDI-specific
antibody of Chlamydia attachment was analyzed. The effect of
antibody to PDI on Chlamydia infection has previously been
evaluated by Davis et al. [17], they observed a temperature
dependent decrease in Chlamydia infection. We further developed
those findings by specifically addressing inhibition of bacterial
attachment as well as entry. When PDI antibody was present prior
to and during bacterial attachment no significant change in the
number of bacteria attached to cells was observed (Figure 7A),
suggesting that Chlamydia was not directly binding PDI. Bacterial
entry in the presence of PDI antibody was also evaluated. The
antibody significantly reduced bacterial entry (Figure 7B) and led
to a persistent attachment phenotype similar to what was seen in
the presence of bacitracin (Figure 4). The inhibition of Chlamydia
entry by PDI antibody corroborated our previous determination
that cell surface PDI reductive function was required for bacterial
uptake.
A polyclonal PDI antibody was used in these experiments, and it
is likely that this antibody would inhibit PDI enzymatic activity by
steric interference. To directly assess the level of PDI enzymatic
activity a turbidimetric assay of insulin disulfide reduction was
performed (Protocol S1). We determined that addition of PDI
antibody to the reaction significantly reduced the rate and level of
insulin reduction, indicating that the antibody had an inhibitory
effect of PDI enzymatic activity (Figure S2). We conclude that
while cellular PDI is necessary for Chlamydia attachment to cells the
bacteria does not initiate attachment through a direct interaction
PDI and Chlamydia Infectivity
PLoS Pathogens | www.plospathogens.org 6 April 2009 | Volume 5 | Issue 4 | e1000357Figure 5. Cell surface PDI reductive function is necessary for bacterial entry. (A) Bacterial entry into CHOK1 cells treated with 3 mM
bacitracin was analyzed after a 2 h incubation at 37uC. Bacteria are shown in green and counter stained with Evans blue. Entry was assessed by
comparing the total number of cell-associated bacteria (permeabilized) and the number of extracellular bacteria (unpermeabilized) in cells that were
treated with 0 mM or 50 mM TCEP. Percent internalization represents 1 minus the number of extracellular bacteria divided by the total number of
bacteria multiplied by 100. The number of extracellular and total bacteria was determined by quantifying the number of bacteria associated with
each cell per field of view in eight separate fields of view containing at least ten cells. Error bars indicate the STDEV. Bacitracin-mediated inhibition
was overcome by the addition of the membrane-impermeable reducing agent TCEP. (B) Infection was evaluated in CHOK1 cells treated with 3 mM
bacitracin 24 h post-infection in cells that had been treated for the initial 2 h of infection with 0 mM or 50 mM TCEP. Development of a normal
infection occurred in cells treated with TCEP, whereas the bacteria remained persistently attached to the outside of untreated cells. (C) Bacterial entry
into CHO6 cells transfected with a vector expressing enzymatically nonfunctional PDI (PDI-4CS) was analyzed after a 2 h incubation at 37uC. Percent
internalization was determined as in (A). Bacterial entry is seen in cells treated with 50 mM TCEP but not in untreated cells.
doi:10.1371/journal.ppat.1000357.g005
PDI and Chlamydia Infectivity
PLoS Pathogens | www.plospathogens.org 7 April 2009 | Volume 5 | Issue 4 | e1000357with PDI. Much like HIV and diphtheria toxin, Chlamydia likely
binds to a cell surface protein(s) that is associated with PDI.
Discussion
Cell surface PDI-mediated disulfide bond reduction is involved
in the infectious entry of a number of viruses. Upon binding of
human immunodeficiency virus (HIV) envelope protein to CD4
receptor and co-receptor (CCR5 or CXCR4) PDI reduces
disulfide bonds in HIV gp120, exposing the gp41 fusion peptide
[28]. The fusion peptide then inserts into the target cell surface
triggering viral and cell membrane fusion. For Newcastle disease
virus, cell surface PDI enzymatic activity is required for the
conformational changes in the viral fusion protein that are
necessary for cell-viral membrane fusion [27]. Similarly PDI-
mediated reduction of Sindbis virus envelope is required for
membrane fusion and release of the viral genome into cells [25].
We have experimentally established that the initial stages of
chlamydial infectivity, attachment and entry, each require host cell
surface PDI; however, the functional participation of PDI was
mechanistically unique at each stage. Cell surface PDI enzymatic
activity was required for Chlamydia entry. Independent of PDI
enzymatic function, PDI was additionally essential for bacterial
attachment to host cells.
The role for protein disulfide exchange in chlamydial infection
has been previously explored using inhibitors. Davis et al. [17] and
Raulston et al. [11] showed that inhibition of cell surface reductive
function by addition of bacitracin or dithio-bis-2-nitrobenzoic acid
(DTNB) adversely affected infectivity of C. trachomatis serovar E.
These results can now be understood in terms of the direct
enzymatic role for PDI in bacterial entry. Raulston et al. [11]
found no inhibition of bacterial attachment using DTNB similar to
our observations with bacitracin. When Davis et al. [17] and
Raulston et al. [11] evaluated the effect of bacitracin or DTNB
Figure 6. PDI interaction with other cell surface proteins is
necessary to rescue bacterial attachment to CHO6 cells. (A)
CHO6 cells transfected with a vector expressing PDI with a gpi-anchor
(PDI-gpi) are marked with a white arrow, untransfected cells are
indicated by a yellow arrow. Cells were fixed and stained for PDI using
PDI-specific antibody. Expression of PDI-gpi led to a large amount of
PDI localized at the cell surface. (B) Cell survival was analyzed 72 h after
DT treatment. CHOK1 cells were extremely sensitive to toxin, whereas
CHO6 cells were relatively resistant. Expression of PDI-gpi in CHOK1 or
CHO6 cells did not alter toxin sensitivity, indicative of an inability of PDI-
gpi to properly interact with other cell surface proteins. (C) Chlamydia
attachment to CHOK1 and CHO6+PDI-gpi was analyzed, bacteria are
shown in green, and PDI is stained red. There was no bacterial
attachment to CHO6+PDI-gpi.
doi:10.1371/journal.ppat.1000357.g006
Figure 7. PDI-specific antibody inhibits Chlamydia entry but not
bacterial attachment. (A) Cells were incubated with 100 mgm l
21
polyclonal PDI-specific antibody or 100 mgm l
21 irrelevant IgG antibody
prior to and during bacterial attachment. Bacteria were allowed to
attach for 1 h and binding was analyzed, bacteria are shown in green
and counter stain is Evans blue. There was no significant difference in
the amount of bacteria that bound to cell with and without PDI
antibody treatment. (B) Entry was analyzed after a 2 h incubation at
37uC. Entry was assessed by comparing the total number of cell-
associated bacteria (permeabilized) and the number of extracellular
bacteria (unpermeabilized) in cells that were treated with100 mgm l
21
polyclonal PDI-specific antibody or 100 mgm l
21 irrelevant IgG anti-
body.
doi:10.1371/journal.ppat.1000357.g007
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a near complete loss of bacterial entry and subsequent infection.
These differences are likely due to the fact that PDI is
constitutively trafficked to the cell surface [24], making bacitracin
inhibition functionally reversible. Both Davis et al. [17] and
Raulston et al. [11] removed the inhibitor after initial bacterial
attachment allowing newly exported PDI to stimulate uptake. In
our experimental design, the inhibitor was present throughout the
course of the infection and if the inhibitor was removed following
attachment, our results were similar to those of Davis et al. [17]
and Raulston et al. [11]. Our data also significantly expand the
previous observations as this now extends the requirement for
disulfide exchange in the process of bacterial infection from one
strain to multiple species of Chlamydia.
A requirement for PDI in chlamydial attachment was
implicated by complementation of the PDI gene in attachment-
deficient mutant CHO6 cells [19]. We anticipated that the oxido-
reductive enzymatic activity of PDI would be required for
bacterial attachment, similar to what is characterized for viral
attachment [25,27,28]. It was a surprise that chlamydial
attachment to CHO6 cells was rescued by complementation with
the enzymatically inactive PDI-4CS. Further evaluation using PDI
inhibitors confirmed that Chlamydia attachment is independent of
cell surface PDI enzymatic activity. Testing of gpi-anchored PDI
tethered to the cell surface suggested that chlamydiae do not
directly bind PDI as the sole target for attachment and this
implicates an interaction with other proteins that require PDI.
Consistent with characterized functions of PDI, it may be PDI’s
function as a chaperone or structural component of a host protein
or protein complex [37] that is required for chlamydial
attachment. PDI chaperone activity is independent of the protein’s
two catalytic domains (a, a9) and PDI functions as a chaperone
outside of the ER [38,39]. PDI could serve to stabilize a host
receptor protein in the correct orientation or context for bacterial
binding. There are also examples of PDI functioning as a
structural subunit of proteins. PDI is the b-subunit of tetrameric
enzyme collagen prolyl 4-hydroxylase, and PDI also makes up half
of the heterodimeric protein complex microsomal triglyceride
transfer protein [40,41]. The receptor that Chlamydia binds may be
a multiprotein complex that includes PDI.
In addition to a requirement of PDI for chlamydial attachment,
it was shown that PDI enzymatic activity was necessary and
sufficient to stimulate chlamydial entry into the host cell. Given the
ability of simple chemical reduction to replace the enzymatic
function of PDI for cell-adherent chlamydiae, it appears that
reduction rather than disulfide exchange is minimally required for
chlamydial entry. It is not known whether PDI functions to reduce
a host or bacterial component to initiate entry. It has been
previously shown that reduction of C. trachomatis L2 EB prior to
infection leads to a decrease in inclusion forming units [42]. This
experiment illustrates the problem of differentiating the effect of
reduction on the infectious process. One can pre-reduce host cells
or bacteria prior to infection, but due to the rapid rate of
reoxidation following the reducing agent removal step and
unknown detrimental effects, especially following pan-blocking of
disulfides by chemical agents, make interpretation of outcomes
confounded and uncertain.
One can speculate that following initial bacterial attachment,
PDI enzymatic activity mediates the establishment of a functional
contact between the chlamydial organism and the host cell leading
to bacterial uptake. It is known that plasma membrane PDI
interacts with a number of host surface proteins. For example, PDI
modifies the adhesion receptors integrin a2b1 and L-selectin
resulting in receptor activation and ligand binding [33]. As well as
modifying cellular surface proteins, PDI binds and modifies
various viral proteins and toxins [25–29]. Thus, there is biological
precedent supporting PDI modification of either host or microbial
factors required for pathogenesis.
Multiple cell surface proteins have been previously implicated in
Chlamydia infectivity, these include epithelial membrane protein 2
[15], mannose 6-phosphate receptor [16], estrogen receptor
complex [17], and platelet-derived growth factor receptor [18].
Unlike PDI, these proteins appear to be involved in the infectivity
of only a subset of chlamydial species or biovars. PDI interacts
with a broad array of host proteins within the endoplasmic
reticulum and at the cell surface allowing for the possibility that
PDI may be an underlying requirement for several independent
Chlamydia-host cell receptor interactions. PDI is involved in protein
folding in the endoplasmic reticulum and PDI expression can be
correlated to the level of secretion of a number of proteins [43–
45]. We established using PDI-specific chemical inhibitors, anti-
PDI antibodies, and chemical reduction of bound organisms that
the function of PDI in chamydial infectivity requires surface
accessible PDI. Proteomic analysis using 2-dimensional gel
electrophoresis of biotin-labeled surface proteins failed to show
any detectible and consistent difference between CHO6 and
CHOK1 cell lines other than for PDI (19 and data not shown).
This suggests that the lack of bacterial attachment to CHO6 cells
is not due to a general defect in plasma membrane protein
composition. If the enzymatic role of PDI is targeted to a host
protein it seems likely that this occurs at the cell surface and not in
a secretion pathway.
Alternative to acting on a host protein, PDI could be targeting
the chlamydial organism. The highly disulfide cross-linked
structure of the chlamydial EB surface proteins that are only
present in the infectious form of the chlamydial organism [7],
suggest that these could be the target for PDI. It has been shown
that reduction of the EB surface is necessary for surface display of
bacterial Hsp70 [11] and it is possible that PDI activates changes
in chlamydial surface proteins that are required to initiate cellular
entry. The chlamydial protein Tarp is translocated into host cells
following bacterial attachment [46]. This translocation occurs via
type III secretion and triggers actin recruitment to the site of
bacterial attachment [46]. Tarp is localized within EB and is not
surface exposed until the commencement of bacterial entry [46].
PDI-mediated reduction of EB surface proteins may be essential to
activate Chlamydia type III secretion into the cell membrane and
subsequent Tarp translocation. The type III secretion system
needle protein of C. trachomatis, CdsF, was recently identified [47].
CdsF is conserved among the chlamydial species, and it is one of
the few bacterial needle proteins that contains cysteine residues.
One can speculate that PDI-mediated reduction of the EB surface
is involved in CdsF function.
While the full intricacies of the Chlamydia-host cell interaction
remain enigmatic these findings illuminate important new details
of the molecular mechanisms involved. Chlamydia attachment and
entry into cells are separable processes that both have a unique
requirement for PDI. Determination of the target of PDI
enzymatic activity that leads to chlamydial entry may be expected
to provide targets for generation of new anti-Chlamydia therapies
and illuminate fundamental cell biological processes exploited by
Chlamydia to mediate pathogen attachment and infectivity.
Materials and Methods
Cell lines, Chlamydia
CHOK1 and CHO6 cells were maintained in RPMI 1640
(Invitrogen, Carlsbad, CA) supplemented with 10% heat-inacti-
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glutamine (Invitrogen), and 1 mM HEPES (Invitrogen). HeLa and
L929 cells were maintained in RPMI 1640 supplemented with
10% FBS. Cells were grown at 37uC in an atmosphere containing
5% CO2. C. trachomatis L2/434/Bu EB and C. psittaci PF6 BC were
purified from L929 cells on 30% and 30–44% discontinuous
Renografin gradients (E. R. Squibb and Sons, Cranbury, NJ) [48]
and stored at 280uC until use.
Chlamydia attachment and infectivity
On the night prior to analysis 1610
5 cells were plated on
12 mm glass coverslips in 24 well plates. Cells were washed with
Hanks buffered saline solution (HBSS) (Invitrogen) and then
incubated with C. trachomatis L2/434/Bu or C. psittaci PF6 BC in
RPMI 1640 with 10% FBS for 1 h at 24uC [19,49–52]. Following
infection cells were washed 4 times with HBSS and methanol fixed
for attachment analysis. For entry and infectivity analysis fresh cell
culture media was added and cells were incubated 2 h for entry
and 24 h for infectivity at 37uC in an atmosphere containing 5%
CO2. For entry analysis cells were fixed with methanol or with 4%
paraformaldehyde, for infectivity assessment cells were fixed with
methanol. Following fixation coverslips were incubated 15 min in
blocking solution (HBSS+2.5% bovine serum albumin (BSA))
(Fisher, Fair Lawn, NJ). Blocking solution was removed and
coverslips were incubated 1 h with mouse anti-Chlamydia MOMP
antibody for C. trachomatis or anti-Chlamydia LPS antibody (Santa
Cruz Biotechnology, Santa Cruz, CA) for C. psittaci and then
washed with HBSS. The wash was followed with a 30 min
incubation with goat anti-mouse AlexaFluor 488 (Invitrogen) and
Evans Blue. Coverslips were mounted in VectaShield Hard Set
mounting media (Fisher) and evaluated on a Nikon Eclipse E800
microscope. When used bacitracin (Sigma, St. Louis, MO) was
added 20 min prior to infection at 3 mM, infection was performed
in media containing 3 mM bacitracin and following infection cells
were maintained in culture media with 3 mM bacitracin. When
used 50 mM TCEP (Pierce, Rockford, IL) in cell culture media
was added following bacterial attachment. For attachment and
entry inhibition analysis cells were incubated for 20 min with
polyclonal rabbit anti-PDI antibody (Stressgen Victoria, BC) or
goat anti-bovine IgG antibody (Pierce, Rockford, IL), the bacterial
inoculum was then added to the antibody containing media and
cell were incubated for 1 h at 24uC. When Stressgen rabbit anti-
PDI antibody was used for PDI visualization, PDI staining was
performed similarly to Chlamydia staining and goat anti-rabbit
AlexaFluor 594 (Invitrogen) was used as a secondary.
For quantification the number of cell-associated apple-green
fluorescing particles of size and shape consistent with 300 nM
organisms were counted in two planes in 8 separate fields of view
containing at least 10 cells. Fluorescent particles that appeared to
be Chlamydia but were larger due to aggregation were enumerated
separately when separate organisms could be discerned or when
distinction was not possible were counted as one to provide a
conservative estimate of bound organisms per cell.
Protein disulfide isomerase expression and silencing
The gene encoding protein disulfide isomerase was cloned from
CHOK1 cDNA and inserted into the expression vector pBICEP-
CMV-1 (Sigma) yielding PDI with a N-terminal FLAG tag. PDI
protein lacking enzymatic function (PDI-4CS) was generated by
mutating 4 essential cysteine residues to serine with the Stratagene
(La Jolla, CA) QuikChange Kit and primers Cys-55,58-Ser F (59 -
TGC CCC GTG GTC TGG CCA CTC CAA AGC TCT GG -
39), Cys-55,58-Ser R (59 - CCA GAG CTT TGG AGT GGC
CAG ACC ACG GGG CA - 39), Cys-399,402-Ser F (59 - TAT
GCC CCC TGG TCT GGC CAC TCC AAG CAG CT - 39),
and Cys-399,402-Ser R (59 - AGC TGC TTG GAG TGG CCA
GAC CAG GGG GCA TA - 39). The gpi-anchor for PDI was
amplified from human folate receptor 1 using primers GPI F (59 -
ATT GCC CGG GGC TGC AGC CAT GAG TGG - 39) and
GPI R (59 – CAA TGT CGA CTC AGC TGA GCA GCC ACA
GCA – 39). The gpi-anchor was than ligated to PDI lacking a stop
codon and the PDI-gpi construct was ligated into the pBICEP-
CMV-1 vector. PDI vectors were transfected into CHO cells with
Effectene (Qiagen, Valencia, CA) following manufacturer’s
instructions. Chlamydia attachment and entry were evaluated
48 h after transfection.
PDI was silenced in HeLa cells with PDI-specific siRNA (59-
GAC CTC CCC TTC AAA GTT GTT –39) (Dharmacon,
Layafette, CO) [30]. Dharmacon siControl non-targeting siRNA
#1 was used at as a negative control. Cells were transfected as
described in Hybiske and Stephens, 2007 with slight modification
[35]. Cells were first transfected in 6 well plates with 10 mlo f
40 mM siRNA duplexes with 5 ml of Olgiofectamine (Invitrogen)
in OptiMem (Invitrogen). 24 h after transfection cells were
transfected again. 90 h after the first transfection cells were
replated on fibronectin (Sigma) coated coverslips in 24 well plates,
and attachment, infectivity, or protein expression was evaluated
6 h after replating.
Diphtheria toxin sensitivity
24 h prior to toxin treatment cells were plated in 96-well plates
at 1610
4 cells per well. Cells were washed once with HBSS and
than incubated for 4 h at 37uC with diphtheria toxin (Biomol,
Plymouth Meeting, PA) (0 or 100 ng ml
21) in HBSS containing
15% FBS. Following incubation cells were washed three times
with HBSS and were than maintain in RPMI 1640 without phenol
red supplemented with 10% FBS, 2 mM glutamine, and 1 mM
Hepes at 37uC in an atmosphere containing 5% CO2. 72 h after
toxin treatment cell viability was determined by Promega
(Madison, WI) CellTiter 96 Aqueous One Cell Proliferation Assay
as directed by the manufacturer’s instructions. Cell viability is
linearly proportional to absorbance.
Quantitative Chlamydia infectivity assay
The number of Chlamydia per cell was determined using a
quantitative PCR based method previously described by Hybiske
and Stephens, [35]. Genomic DNA from CHOK1 cells infected
with C. trachomatis was isolated using the High-Pure PCR template
preparation kit (Roche, Indianapolis, IN). Purified genomic DNA
was used as a template in quantitative PCR to determine the
relative levels of chlamydial (16S) and CHOK1 (ß-globin) genomic
equivalents.
Accession numbers
The NCBI Entrez (http://www.ncbi.nlm.nih.gov/sites/entrez?db
=protein) accession number for genes discussed in this paper are
Homo sapiens PDI (NP_006840) and Cricetulus griseus PDI
(AAM_00284).
Supporting Information
Figure S1 Bacitracin does not affect Chlamydia attachment to
HeLa cells, but it completely inhibits subsequent bacterial
infection. Prior to infection, HeLa cells were incubated 20 min
with 0 mM or 3 mM bacitracin. Cells were then infected with
Chlamydia in media with or without bacitracin. Addition of
bacitracin had no significant effect on bacterial attachment (top
panel). Bacterial infection was analyzed 24 h after initial
PDI and Chlamydia Infectivity
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of a productive infection, as indicated by the presence of large
bacteria containing vacuoles, was observed (bottom panel). When
bacitracin was present throughout the course of the infection, the
bacteria remained persistently attached to cells and no productive
infection occurred (bottom panel). These results are similar to our
analysis of the effect of bacitracin on Chlamydia infection of
CHOK1 cells (Figure 4).
Found at: doi:10.1371/journal.ppat.1000357.s001 (2.88 MB TIF)
Figure S2 Polyclonal PDI antibody inhibits PDI enzymatic
activity. PDI enzymatic activity was evaluated by measuring the
rate of insulin reduction spectrophotometrically at 650 nm as
turbidity formation from the precipitation of the insulin B chain
following insulin reduction. A control reaction (Control) was
performed without PDI. A reaction with PDI (PDI) and with PDI
preincubated with PDI-specific antibody (PDI+Ab) was also done.
Readings were taken every 5 min for 1 h. Error bars indicate the
standard of deviation from three separate experiments performed
on the same day.
Found at: doi:10.1371/journal.ppat.1000357.s002 (0.57 MB TIF)
Protocol S1 Supporting Protocol
Found at: doi:10.1371/journal.ppat.1000357.s003 (0.03 MB
DOC)
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